Phased Rx Drug Approval In Europe Could Help Switches – EU Execs
This article was originally published in The Pink Sheet Daily
Executive Summary
Phased approval would mean a more “conditional” approval for an Rx product at the initial marketing stage that could progress to full marketing authorization and eventually might end with a non-prescription switch.